Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes

Mary Eapen, MBBS, Joanne Kurtzberg, MD, Mei-Jie Zhang, PhD, Adam M. Mendizabal, PhD, Ka Wah Chang, MD, Michel Duval, MD, Mingwei Fei, MS, Steven Neudorf, MD, Satiro N. De Oliveira, MD, Donna A. Wall, MD, Kirk R. Schultz, MD, Mary M Horowitz, MD MS, John E. Wagner, MD

Blood (2016) 128 (22): 1231.

https://doi.org/10.1182/blood.V128.22.1231.1231

Published: 2016

Journal Articles

Intergraft Variability in Nonhematopoietic Immunoregulatory Cell Number and Expression of Immune Checkpoint Inhibitor Receptors and Ligands in Both Allo- and Autografts: Potential Target for Intervention

Qingdong Guan, MD PhD, Scott Gilpin, James Doerksen, Lauren Bath, Tracey Lam, Kristjan Paulson, FRCPC, Pascal Lambert, Yun Li, Donna A. Wall, MD

Blood (2016) 128 (22): 3382.

https://doi.org/10.1182/blood.V128.22.3382.3382

Published: 2016

Journal Articles

Proteomic Analysis of Reprograming of Mesenchymal Stem/Stromal Cells (MSC) Following Interferon Gamma Identifies Pathways That Are Upregulated in Suppression

Qingdong Guan, MD PhD, Tanner Shpiruk, MSc, Peyman Ezzati, PhD, Oleg Krokhin, PhD, Scott Gilpin, James Doerksen, Victor Spicer, Swaroop Bhagwat, MSc, John Wilkins, PhD, Donna A. Wall, MD

Blood (2015) 126 (23): 384.

https://doi.org/10.1182/blood.V126.23.384.384

Published: 2015

Journal Articles

Plerixafor Successfully Rescues Poor Mobilizers Resulting in Adequate CD34 Cell Numbers However Stem Cell Products Yield Lower Numbers of CFU/CD34 and Delayed Neutrophil Engraftment

David Szwajcer, MD FRCPC, Anna Blankstein, Miranda M. Charette, MD, Qingdong Guan, MD PhD, Donna A. Wall, MD

Blood (2014) 124 (21): 2450.

https://doi.org/10.1182/blood.V124.21.2450.2450

Published: 2014

Journal Articles

Recovery Of Myeloid Derived Suppressor Cell Subsets Following Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation

Qingdong Guan, PhD, Anna Blankstein, Anjos Karla, Oleksandra Synova, Marie Tulloch, Angeline Giftakis, Bin Yang, PhD, Geoff D. E. Cuvelier, MD, FRCP(C), Zhikang Peng, MD, Donna A. Wall, MD

Blood (2013) 122 (21): 4617.

https://doi.org/10.1182/blood.V122.21.4617.4617

Published: 2013

Journal Articles

Striking Predictive Power For Relapse and Decreased Survival Associated With Detectable Minimal Residual Disease by IGH VDJ Deep Sequencing Of Bone Marrow Pre- and Post-Allogeneic Transplant In Children With B-Lineage ALL: A Subanalysis Of The COG ASCT0431/PBMTC ONC051 Study

Michael A. Pulsipher, MD, Christopher S Carlson, PhD, Krailo Mark, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, Michael Kalos, PhD, Desmarias Cindy, PhD, David Williamson, PhD, Gastier-Foster Julie, MD, PhD, Michael J. Borowitz, MD, PhD, Stephan A. Grupp, MD, PhD

Blood (2013) 122 (21): 919.

https://doi.org/10.1182/blood.V122.21.919.919

Published: 2013

Journal Articles

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, Julie M. Gastier-Foster, PhD, Michael J. Borowitz, MD, PhD, Rakesh Goyal, MD, MRCP, Sharon Gardner, MD, William L. Carroll, MD, Elizabeth Raetz, MD, Stephan A. Grupp, MD, PhD

Blood (2012) 120 (21): 470.

https://doi.org/10.1182/blood.V120.21.470.470

Published: 2012

Journal Articles

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Katie Perkins, NP, Joie Davis, NP, Susan Price, RN, Julie Niemela, PhD, Andreas R. Huber, MD, Donna A. Wall, MD, Stefania Pittaluga, MD, PhD, Thomas A. Fleisher, MD, V. Koneti Rao, MD

Blood (2012) 120 (21): 2149.

https://doi.org/10.1182/blood.V120.21.2149.2149

Published: 2012

Journal Articles

No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

John E. Wagner, MD, Mary Eapen, MBBS, Shelly L Carter, ScD, Paul R. Haut, MD, Edward Peres, MD, Kirk R. Schultz, MD, Jason Thompson, Donna A. Wall, MD, Joanne Kurtzberg, MD

Blood (2012) 120 (21): 359.

https://doi.org/10.1182/blood.V120.21.359.359

Published: 2012

Journal Articles

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Michael A. Pulsipher, MD, Bryan Langholz, PhD, Donna A. Wall, MD, Kirk R. Schultz, MD, Nancy Bunin, MD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Sharon Gardner, MD, Julie M. Gastier-Foster, PhD, Denise Howrie, PharmD, Rakesh Goyal, MD, MRCP, Douglas James, MD, MRCP, Michael J. Borowitz, MD, PhD, Yvonne Jean Barnes, RN MSN CPNP, Shivanand R. Patil, PhD, David T Teachey, MD, Candace Taylor, CCRP, Stephan A Grupp, MD, PhD

Blood (2011) 118 (21): 837.

https://doi.org/10.1182/blood.V118.21.837.837

Published: 2011

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience

Blood (2011) 118 (21): 3074.

https://doi.org/10.1182/blood.V118.21.3074.3074

Published: 2011

Journal Articles

Modest Prolongation of Survival for Patients 60-80 Year at Time of Acute Myelogenous Leukemia (AML) Diagnosis Who Are Treated with Conventional AML Therapy: A Provincial Cohort Analysis.

Maneesh Sud, BSc, Demers Alain, PhD, Rajat Kumar, FRCP, Grace Musto, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Erin Richardson, Morel Rubinger, MD, FRCPC, Brent Allan Schacter, MD, Donna A. Wall, MD, David Szwajcer, MD

Blood (2009) 114 (22): 4125.

https://doi.org/10.1182/blood.V114.22.4125.4125

Published: 2009

Journal Articles

Inflammatory Markers and Autoantibodies That Correlate with Early and Late Onset of New Onset Pediatric Chronic Graft-Versus-Host Disease (GVHD).

Hisaki Fujii, MD, Kevin She, MSc, Soudabeh Aslanian, BSc, Hiromi Shimizu, BSc, Mark Krailo, PhD, Zhengjia Chen, MS, Frederick Goldman, MD, PhD, Donna A. Wall, MD, PhD, Andrew L. Gilman, MD, Kirk R. Schultz, MD

Blood (2006) 108 (11): 3232.

https://doi.org/10.1182/blood.V108.11.3232.3232

Published: 2006

Journal Articles

Fewer Relapses Following Unrelated Donor Cord Blood (UDCB) Compared to Related or Unrelated Bone Marrow (BM) or Peripheral Blood Cell (PBSC) Transplant in the Treatment of Childhood Relapsed and Very High Risk Acute Lymphoblastic Leukemia (ALL).

Donna A. Wall, MD, Ka Wah Chan, MD, Bess Bowen, Lorraine Alexander, Michael Grimley, MD

Blood (2006) 108 (11): 3153.

https://doi.org/10.1182/blood.V108.11.3153.3153

Published: 2006

Journal Articles

Post-Thaw Colony Forming Unit (CFU) Counts and Yield Are the Most Important Predictors of Engraftment and Survival Following Unrelated Donor Cord Blood Transplantation (CBT): A COBLT Study Report.

Donna A. Wall, MD, Elizabeth L. Wagner, M.P.H., Shelly L. Carter, Sc.D., Adam M. Mendizabal, MS, Mitchell S. Cairo, MD, Nancy A. Kernan, MD, Mary Laughlin, MD, Joanne Kurtzberg, MD

Blood (2005) 106 (11): 2046.

https://doi.org/10.1182/blood.V106.11.2046.2046

Published: 2005

Journal Articles

Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study.

David A. Jacobsohn, MD, Kirk R. Schultz, MD, Frederick Goldman, MD, Donna A. Wall, MD, Mark Krailo, PhD, Zhengjia Chen, MS, Jeffrey M. Lipton, MD, PhD, Jean E. Sanders, MD, Andrew L. Gilman, MD

Blood (2005) 106 (11): 5375.

https://doi.org/10.1182/blood.V106.11.5375.5375

Published: 2005

NARROW

Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes

Intergraft Variability in Nonhematopoietic Immunoregulatory Cell Number and Expression of Immune Checkpoint Inhibitor Receptors and Ligands in Both Allo- and Autografts: Potential Target for Intervention

Proteomic Analysis of Reprograming of Mesenchymal Stem/Stromal Cells (MSC) Following Interferon Gamma Identifies Pathways That Are Upregulated in Suppression

Plerixafor Successfully Rescues Poor Mobilizers Resulting in Adequate CD34 Cell Numbers However Stem Cell Products Yield Lower Numbers of CFU/CD34 and Delayed Neutrophil Engraftment

Recovery Of Myeloid Derived Suppressor Cell Subsets Following Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation

Striking Predictive Power For Relapse and Decreased Survival Associated With Detectable Minimal Residual Disease by IGH VDJ Deep Sequencing Of Bone Marrow Pre- and Post-Allogeneic Transplant In Children With B-Lineage ALL: A Subanalysis Of The COG ASCT0431/PBMTC ONC051 Study

The Relationship of Acute Gvhd and Pre- and Post-Transplant Flow-MRD to the Incidence and Timing of Relapse in Children Undergoing Allogeneic Transplantation for High Risk ALL: Defining a Target Population and Window for Immunological Intervention to Prevent Relapse

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

A Randomized Trial of Sirolimus-Based Graft Versus Host Disease (GVHD) Prophylaxis After Hematopoietic Stem Cell Transplantation (HSCT) in Selected Patients with CR1 and CR2 ALL: Results From Children's Oncology Group Study ASCT0431

Allogeneic Hematopoietic Cell Transplantation (HCT) for Neuroblastoma (NB): The CIBMTR Experience

Modest Prolongation of Survival for Patients 60-80 Year at Time of Acute Myelogenous Leukemia (AML) Diagnosis Who Are Treated with Conventional AML Therapy: A Provincial Cohort Analysis.

Inflammatory Markers and Autoantibodies That Correlate with Early and Late Onset of New Onset Pediatric Chronic Graft-Versus-Host Disease (GVHD).

Fewer Relapses Following Unrelated Donor Cord Blood (UDCB) Compared to Related or Unrelated Bone Marrow (BM) or Peripheral Blood Cell (PBSC) Transplant in the Treatment of Childhood Relapsed and Very High Risk Acute Lymphoblastic Leukemia (ALL).

Post-Thaw Colony Forming Unit (CFU) Counts and Yield Are the Most Important Predictors of Engraftment and Survival Following Unrelated Donor Cord Blood Transplantation (CBT): A COBLT Study Report.

Eosinophilia, Positive ANA, and Hypergammaglobulinemia at Presentation of Extensive Chronic GVHD in Children: A Children’s Oncology Group Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only